<DOC>
	<DOCNO>NCT01309659</DOCNO>
	<brief_summary>The purpose study determine whether treatment unexplained anemia old adult short course weekly intravenous iron infusion improve physical activity therefore quality life .</brief_summary>
	<brief_title>Trial To Evaluate Efficacy Intravenous Iron Older Adults With Unexplained Anemia</brief_title>
	<detailed_description>There tremendous morbidity mortality associate anemia elderly increase proportion elderly adults underscore population 's attributable risk anemia . As potentially modifiable factor , urgent need exists delineate impact anemia correction elderly . The Partnership Anemia : Clinical Translational Trials Elderly ( PACTTE ) consortium create focus treatment strategy anemia elderly patient . The data present protocol provide compelling rationale evaluate impact well-tolerated IV iron preparation community dwell old anemic adult intermediate serum ferritin value . Subjects 65 year old adult unexplained anemia serum ferritin 20 200 ng/mL . Subjects randomize 1:1 basis either receive 5 week course treatment intravenous iron immediately waitlist control group receive treatment intravenous iron follow 12 week observation period . Both group ultimately receive 200mg intravenous iron sucrose weekly 5 week determine lead improvement 6 Minute Walk Test result . The primary endpoint change 6 Minute Walk Test distance baseline 12 week . The procedure protocol include use outcome tool select ability show improvement quality life patient population . Blood sample also collect analysis local lab ( safety test - eg hemoglobin Hb ) central lab research purpose .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric oxide , saccharated</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Age ≥ 65 year old Hemoglobin concentration ≥ 9.0 g/dL &lt; 11.5 g/dL ( woman ) &lt; 12.7 g/dL ( men ) Unexplained anemia Serum ferritin level ≥ 20 ≤ 200 ng/mL Able walk without use walker , motorize device assistance another person . Able understand willing provide write informed consent absence dementia Must able understand speak English Red blood cell transfusion within past 3 month Use erythropoiesis stimulate agent ( ESA ) past 3 month Intravenous Iron Infusions within past 3 month Distance baseline 6MWT ( 6 minute walk test ) median age sex History unstable angina myocardial infarction past 3 month History stroke TIA ( transient ischemic attack ) past 3 month Uncontrolled hypertension ( diastolic blood pressure &gt; 100 mm Hg systolic blood pressure &gt; 160 mm Hg 2 separate occasion ) Positive fecal occult blood test within screen period Elevated AST ( aspartate aminotransferase ) ALT ( alanine aminotransferase ) ≥ 2x upper limit normal Documented anaphylactic reaction iron sucrose infusion past Subjects initiated oral iron supplementation within last 6 week , initiate oral iron within last 3 month least one gram/dL improvement Hb since start oral iron supplementation</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Unexplained anemia</keyword>
	<keyword>elderly</keyword>
	<keyword>geriatric</keyword>
	<keyword>old adult</keyword>
	<keyword>UAE</keyword>
	<keyword>65</keyword>
	<keyword>iron</keyword>
	<keyword>pactte</keyword>
	<keyword>pactee</keyword>
	<keyword>age</keyword>
	<keyword>age</keyword>
	<keyword>old</keyword>
	<keyword>old</keyword>
</DOC>